Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

IASO and Umoja Partner to Develop Off-the-Shelf CAR-T Gene Therapies

publication date: Jan 4, 2024

Shanghai IASO Biotherapeutics announced an extensive collaboration with Seattle’s Umoja Biopharma to develop off-the-shelf, CAR T-cell gene therapies. IASO Bio will use Umoja’s rapamycin-activated cytokine receptor (RACR™) platform to develop two ex vivo iPSC-derived chimeric antigen receptor (CAR)-bearing cell therapies. IASO will be responsible for worldwide development and commercialization of both products. In exchange, Umoja will receive rights to CAR cassettes for two targets to advance two in vivo product candidates. Umoja will be responsible for product development outside of Greater China, and IASO for the Greater China territory. The two companies established their first collaboration in late 2022. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital